Global Dermatology Drugs Market Size By Application (Acne, Dermatitis, Psoriasis, Skin Cancer), By Route of Administration (Topical, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Geographic Scope And Forecast

Dermatology Drugs Market Size And Forecast

Dermatology Drugs Market size was valued at USD 18.83 Billion in 2022 and is projected to reach USD 42.77 Billion by 2030, growing at a CAGR of 10.80% from 2023 to 2030.

The availability of medical resources for diagnosing and treating skin conditions, nutritional deficiencies brought on by unhealthful eating habits, growing awareness of lifestyle diseases, rising pollution levels, and a lack of population immunity are some of the driving factors expected to contribute to the growth of the global market for dermatology drugs. The expanding purchasing power and rising per capita income are other driving factors in this industry.

Global Dermatology Drugs Market Definition

Dermatology is a field of medicine that focuses on identifying, preventing, and treating conditions that affect the skin, including those that affect the hair and nails. Medications used to treat skin conditions are referred to as dermatology drugs. Drugs used in dermatology are intended to prevent skin conditions. Laser therapy, topical and systemic drugs, photodynamic therapy, radiation, vitiligo surgery, and dermatological surgery are all forms of skin treatment.

These dermatology drugs are also applied topically to the skin to preserve attributes like radiance and health. The market for dermatology drugs is made up of companies (organizations, sole proprietors, and partnerships) that sell the medications they make to treat skin conditions. This sector of the economy is made up of businesses that manufacture medications to treat conditions like rosacea, dermatitis, hyperhidrosis, androgenic alopecia, acne, microbial infections, and other skin disorders.

Global Dermatology Drugs Market Overview

With more people suffering from dermatitis, fungal infections, and acne, the market for dermatological drugs is growing. The American Association of Dermatologists reports that approximately 50 million people in the US alone suffer from acne. Numerous factors, such as poor self-care, excessive sweating, eating hot foods, and donning restrictive clothing, can result in skin problems and other related problems. The market is seeing an increase in the sales of medicines used for treatments as a result. Increased public awareness of skin and hair infections has been shown to create an opportunity for the sector. Increased awareness has led to an increase in the sales of over-the-counter (OTC) drugs, which are widely used to treat hair loss and acne. Most children and teenagers experience skin issues like irritation, acne, and excessive sweating as a result of hormonal changes.

The market is expected to keep growing because of the rise in demand for dermatological drugs that are frequently applied topically as anti-inflammatory agents and cleansers. As a result of the growing demand for novel, effective, and reasonably priced medicines, additional factors to take into account include a growth in R&D spending by industry leaders for the development and clinical testing of new treatments. The pharmaceutical sector is growing as cases of skin cancer and other diseases are on the rise. However, the sector won’t be able to reach its full potential due to a variety of negative effects and inappropriate administration of dermatological treatments, as well as regulatory restrictions and standards.

Global Dermatology Drugs MarketSegmentation Analysis

The Global Dermatology Drugs Market Segmented On The Basis Of Application, Route of Administration, Distribution Channel, and Geography.

Dermatology Drugs Market, By Application

• Acne
• Dermatitis
• Psoriasis
• Skin Cancer
• Others

Based on Application, The market is bifurcated into Acne, Dermatitis, Psoriasis, Skin Cancer, and Others. In 2021, the market was dominated by the psoriasis category in terms of revenue. The immune system mistakenly attacks healthy skin cells, which results in psoriasis. Psoriasis is not a disease that spreads easily. Swollen fingers and toes, foot pain, lower back pain, nail changes, and eye irritation are all symptoms of the disease. Stress, skin injuries, infections, some medicines, and heavy drinking can all cause psoriasis. Although it affects people of all ages, psoriasis is most common in adults, which increases the demand for dermatology drugs globally.

Dermatology Drugs Market, By Route of Administration

• Topical
• Oral
• Parenteral Administration

Based on Route of Administration, The market is bifurcated into Topical, Oral, and Parenteral Administration. The parenteral administration market segment completely dominated in 2021. The segment’s dominance is due to the development of biologics for the treatment of dermatological conditions. Additionally, it is projected that increased patient demand for tropical therapies will boost the products’ sales. Because oral medications have been approved by the US FDA, it is anticipated that the oral category would see a significant CAGR during the projected period.

Dermatology Drugs Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Based on Distribution Channel, The market is bifurcated into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The Hospital Pharmacies segment has the largest share of the Global Dermatology Drugs Market as a result of an increase in patient visits and sales of prescription-only drugs for the treatment of dermatological skin diseases. This market is growing as a result of consumers’ preference for neighborhood pharmacies and the availability of low-cost OTC products. Over the course of the anticipated period, it is estimated that the online pharmacies market would expand at a profitable CAGR due to the extensive use of online portals and websites like Amazon and Walmart.

Dermatology Drugs Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East And Africa

On the basis of Regional Analysis, The Global Dermatology Drugs Market is segmented on the basis of geography into North America, Europe, Asia Pacific, Latin America, Middle East And Africa. Over the forecast period, Asia Pacific is anticipated to experience the highest CAGR growth. The most populous countries in the globe, such as China and India, are anticipated to have a high number of skin disease patients during the projection period. The highest growth in this market is being attributed to factors such as health services, life science industry advancements, and increased awareness of skin conditions and their treatments. Additionally, this industry is expanding at a fast rate due to rising incomes and consumer power.

Key Players

The “Global Dermatology Drugs Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Novartis AG, Amgen Inc., AbbVie Inc., Johnson & Johnson, Leo Pharma A/S, Eli Lilly and Company, GlaxoSmithKline Plc, AstraZeneca plc, Pfizer Inc., Merck KGaA. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.